Frailty in Medicare Advantage Beneficiaries and Traditional Medicare Beneficiaries.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 Aug 2024
Historique:
medline: 1 9 2024
pubmed: 1 9 2024
entrez: 30 8 2024
Statut: epublish

Résumé

A growing proportion of the population is enrolling in Medicare Advantage (MA), which typically offers additional benefits compared with traditional Medicare (TM). To determine whether frailty and frailty trajectories differ between MA enrollees and TM enrollees. This retrospective cohort study used data from the National Health and Aging Trends Study (2015-2016). Analyses were conducted from August 2023 to March 2024. Participants were community-dwelling Medicare beneficiaries aged 65 years and older. Enrollment in MA vs TM. Frailty was calculated by a frailty index (FI) (range, 0-1, with higher values indicating greater frailty) and the Fried Frailty Phenotype (FFP) score (range, 0-5, with higher values indicating greater frailty). Physical performance, including Short Physical Performance Battery (SPPB) score (range, 0-12, with higher values indicating better performance), and gait speed (meters per second) were measured. The primary outcome was the difference in FI and FFP scores from the 2015 baseline assessment to the 2016 follow-up assessment. Secondary outcomes include the 1-year changes in SPPB and gait speed. The final cohort consisted of 7063 participants (2775 [23.1%] aged >80 years; 4040 [54.7%] female), representing a sample of the 38.8 million beneficiaries. There were 2583 (35.0%) MA enrollees (13.6 million) and 4480 (65.0%) TM enrollees (25.2 million). At baseline, the FI score was similar between MA and TM enrollees (mean [SD], 0.22 [0.15] vs 0.21 [0.14]), although MA enrollees had worse phenotypic frailty (496 participants [15.2%] vs 811 participants [13.7%] considered frail by FFP score), SPPB scores (mean [SD], 6.91 [3.34] vs 7.21 [3.27]), and gait speed (0.79 [0.24] m/s vs 0.82 [0.23] m/s) than TM enrollees. One year later, there were no differences between MA and TM enrollees in the 1-year change in FI score (mean [SD], 0.016 [0.071] vs 0.014 [0.066]; adjusted mean difference, 0.001 [95% CI, -0.004 to 0.005]), FFP score (mean [SD], 0.017 [1.004] vs 0.007 [0.958]; adjusted mean difference, -0.009 [95% CI, -0.067 to 0.049]), SPPB score (mean [SD], -0.144 [2.064] vs -0.211 [1.968]; adjusted mean difference, 0.068 [95% CI, -0.076 to 0.212]), and gait speed (mean [SD], -0.0160 [0.148] m/s vs -0.007 [0.148] m/s; adjusted mean difference, -0.010 m/s [95% CI, -0.067 to 0.049 m/s]). In this cohort study of Medicare beneficiaries from 2015, MA enrollees experienced similar declines in frailty over 1 year compared with TM enrollees. Future work should examine whether the specific types of services covered by health insurance can impact frailty and health trajectories for older adults.

Identifiants

pubmed: 39212986
pii: 2823016
doi: 10.1001/jamanetworkopen.2024.31067
pmc: PMC11365002
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2431067

Subventions

Organisme : NIA NIH HHS
ID : K24 AG073527
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG078894
Pays : United States

Références

Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
JAMA Health Forum. 2022 Aug 5;3(8):e222585
pubmed: 36200634
JAMA Netw Open. 2022 Oct 3;5(10):e2235161
pubmed: 36201213
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1427-34
pubmed: 26297656
Med Care Res Rev. 2021 Dec;78(6):693-702
pubmed: 32744130
Health Aff (Millwood). 2019 Apr;38(4):554-560
pubmed: 30933606
JAMA. 2021 Aug 17;326(7):628-636
pubmed: 34402828
J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1143-1147
pubmed: 32145016
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Am Geriatr Soc. 2023 Oct;71(10):3189-3198
pubmed: 37289180
J Aging Health. 2019 Feb;31(2):280-292
pubmed: 29254407
J Am Geriatr Soc. 2020 Aug;68(8):1771-1777
pubmed: 32274807
J Am Geriatr Soc. 2003 Nov;51(11):1610-4
pubmed: 14687391
Eur J Prev Cardiol. 2022 May 25;29(7):1008-1014
pubmed: 33846721
J Gerontol B Psychol Sci Soc Sci. 2020 Jan 1;75(1):107-113
pubmed: 29590462
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Gerontol A Biol Sci Med Sci. 2023 Jul 8;78(7):1198-1203
pubmed: 36630699
JAMA. 2022 Jun 28;327(24):2393-2394
pubmed: 35604657
Health Aff (Millwood). 2021 Jun;40(6):937-944
pubmed: 34097516
J Gen Intern Med. 2020 May;35(5):1516-1522
pubmed: 32072368
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
Arch Gerontol Geriatr. 2020 Sep - Oct;90:104119
pubmed: 32562956
Lancet. 2019 Oct 12;394(10206):1365-1375
pubmed: 31609228
PM R. 2015 Feb;7(2):130-4
pubmed: 25217822
BMC Public Health. 2020 Jan 23;20(1):99
pubmed: 31973695
Alzheimers Dement (N Y). 2021 Mar 23;7(1):e12150
pubmed: 33778149
Health Aff (Millwood). 2020 May;39(5):809-818
pubmed: 32364865
Health Aff (Millwood). 2023 Sep;42(9):1203-1211
pubmed: 37669490
J Am Geriatr Soc. 2021 Apr;69(4):1057-1062
pubmed: 33377190
N Engl J Med. 2012 Jan 12;366(2):150-7
pubmed: 22236225

Auteurs

Sandra M Shi (SM)

Hebrew SeniorLife, Marcus Institute for Aging Research, Harvard Medical School, Boston, Massachusetts.

Brianne Olivieri-Mui (B)

Department of Public Health and Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts.

Chan Mi Park (CM)

Hebrew SeniorLife, Marcus Institute for Aging Research, Harvard Medical School, Boston, Massachusetts.

Stephanie Sison (S)

Department of Internal Medicine, University of Massachusetts Chan Medical School, Worcester.

Ellen P McCarthy (EP)

Hebrew SeniorLife, Marcus Institute for Aging Research, Harvard Medical School, Boston, Massachusetts.

Dae H Kim (DH)

Hebrew SeniorLife, Marcus Institute for Aging Research, Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH